SCHEMBL6892182

SCHEMBL6892182

COC(=O)c1cccc2c1c1c(O)cc(-c3ccc(Cl)cc3)cc1n2Cc1cccc(Cc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.43
TBXA2R P21731 5/20 0.43
ALOX5 P09917 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
MAPT P10636 4/20 0.39
POLB P06746 1/20 0.39
P2RX7 Q99572 1/20 0.38
MAPK8 P45983 1/20 0.38
MAPK9 P45984 1/20 0.38
ALDH1A1 P00352 2/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
KDM4E B2RXH2 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PLA2G2A P14555 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
PPARG P37231 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6690879 0.94 DRD2 (0.47) DRD2TBXA2RALOX5SLC6A4SLC6A3
SCHEMBL6898378 0.93 ACMSD (0.39) MAPTMAPK8ALDH1A1GAAPKM
SCHEMBL6894303 0.93 DRD2 (0.44) DRD2TBXA2RSLC6A4SLC6A3MAPT
SCHEMBL6895138 0.91 HSP90AA1 (0.43) DRD2TBXA2RALOX5SLC6A4SLC6A3
SCHEMBL6897038 0.91 PLA2G2A (0.46) DRD2TBXA2RSLC6A4SLC6A3MAPT
SCHEMBL6895281 0.89 FAAH (0.44) DRD2TBXA2RSLC6A4SLC6A3MAPT
SCHEMBL6890338 0.89 MAPT (0.44) DRD2TBXA2RSLC6A4SLC6A3MAPT
SCHEMBL6893709 0.89 MAPT (0.47) MAPTPOLBALDH1A1GAAPKM
SCHEMBL6694644 0.88 AR (0.45) MAPTMAPK8ALDH1A1GAAPKM
SCHEMBL6897098 0.88 CYP19A1 (0.44) DRD2TBXA2RSLC6A4SLC6A3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed